| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $3.0B | $2.6B | $2.2B | $1.8B | $1.3B |
| Cost of Revenue | $1.6B | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.5B |
| Operating Income | $0.5B | $0.4B | $0.2B | $0.1B | $-0.5B |
| Net Income | $0.4B | $0.2B | $0.1B | $-0.0B | $-0.6B |
| EPS (Basic) | $1.71 | $0.77 | $0.39 | $-0.01 | $-3.73 |
| EPS (Diluted) | $1.66 | $0.74 | $0.37 | $-0.01 | $-3.73 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $8.0B | $7.2B | $7.0B | $6.6B | $6.3B |
| Current Assets | $0.4B | $0.2B | $0.2B | $0.1B | $0.1B |
| Cash & Equivalents | $0.2B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $4.9B | $4.5B | $4.8B | $4.5B | $4.2B |
| Current Liabilities | $0.6B | $0.5B | $0.6B | $0.5B | $0.4B |
| Stockholders' Equity | $3.1B | $2.6B | $2.3B | $2.1B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.6B | $0.5B | $0.2B | $-0.0B |
| Investing Cash Flow | $-0.7B | $-0.3B | $-0.6B | $-0.2B | $-0.3B |
| Capital Expenditures | $0.9B | $0.5B | $0.7B | $0.6B | $0.3B |
| Financing Cash Flow | $0.0B | $-0.3B | $0.1B | $0.0B | $0.3B |